GlaxoSmithKline has supported the Cancer Research Institute across patient education and thought leadership, providing sponsorship for the CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference, inaugural Immunotherapy Patient Summit, and multi-year sponsorship of the Immunotherapy Patient Summit series. In addition, GSK has provided unrestricted support to advance the Cancer Research Institute mission.
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111
Dr. Benjamin Vincent recaps highlights from Day 4 of the 2022 CRI-ENCI-AACR International Cancer Immunotherapy Conference, covering cancer vaccines and innovative technologies to study tumor immunity.
Dr. E. John Wherry dicusses cell therapies and the cancer ecosystem during Day 3 of the 2022 CRI-ENCI-AACR International Cancer Immunotherapy Conference (CICON22).